☆ 4.6 Article

Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes

Natalia Aptsiauri et al.

Summary: HLA class I molecules play a crucial role in tumor recognition and T cell-mediated elimination, and loss of tumor HLA class I expression reduces antigen presentation and facilitates cancer immune evasion. This review summarizes the current advances in understanding the mechanisms of MHC/HLA class I alterations during tumor progression and highlights the importance of detecting and correcting tumor HLA expression absence to improve immunotherapy protocols.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Review Immunology

HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy

Per Anderson et al.

Summary: T cell-mediated immune therapies show promise in treating various malignancies, but only a small fraction of patients respond to treatment. Understanding the lack of responses and identifying predictive biomarkers is crucial. CRC is a heterogeneous disease, and the loss of HLA-I in CRC is associated with immune evasion and metastasis.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Article Oncology

Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer

Meike Kohlruss et al.

Summary: The study investigated the predictive and prognostic value of different molecular subtypes in gastric carcinomas, with a focus on chromosomal instability (CIN) in the context of neoadjuvant chemotherapy (CTx). It was found that EBV(+), MSI-H, and GS were associated with increased survival compared to CIN in resected tumors, while CIN-substantial was a negative prognostic factor in tumors with CTx. CIN-high predicted tumor regression in biopsies before CTx but was not prognostically relevant.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Editorial Material Oncology

Understanding the impact of immune-mediated selection on lung cancer evolution

Rachel Rosenthal et al.

Summary: Understanding how tumors evolve and evade immune recognition is crucial for improving cancer immunotherapy and patient outcomes. Integration of multi-region genomic, transcriptomic, epigenomic, pathology, and clinical data is essential for systematic examination of immune escape mechanisms and implications for immunotherapy approaches.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Immunology

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

Karthik Dhatchinamoorthy et al.

Summary: Loss of MHC I antigen presentation is common in many cancers, which may impair immune responses and affect the efficacy of immunotherapy. Studies have discussed underlying mechanisms through which some cancers evade immune killing by shutting down the MHC I pathway, and proposed potential strategies to overcome this limitation.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Oncology

MHC heterogeneity and response of metastases to immunotherapy

Ignacio Algarra et al.

Summary: Immunotherapy has proven to be effective in fighting cancer, but tumors and metastases can develop escape mechanisms to evade immune responses, such as downregulating the expression of MHC class I molecules. Understanding and reversing these escape mechanisms is crucial for personalized cancer treatment with immunotherapy.

CANCER AND METASTASIS REVIEWS (2021)

Add to Collection

Article Oncology

Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer

Maria Antonia Garrido et al.

Summary: Loss of HLA genes can lead to reduced recognition of specific tumor peptides by cytotoxic T lymphocytes, favoring cancer immune escape. These alterations may be caused by genomic defects, such as loss of heterozygosity at chromosomes 6 and 15 (LOH-6 and LOH-15), where HLA-I genes are located.

CANCERS (2021)

Add to Collection

Article Oncology

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy

Zi-Ning Liu et al.

Summary: The study compared the predictive accuracies of five published TRG systems and found that the four-tier Becker system outperformed others in predicting overall survival and disease-free survival in locally advanced gastric cancer patients.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer

Jian-Wei Xie et al.

Summary: The study confirms the prognostic value of TRG for AGC patients treated with NACT plus surgery and identifies oxaliplatin-based regimens as independent predictors of TRG. Oxaliplatin-based regimens improve tumor response and may benefit overall survival in patients with nonsignet ring cell carcinoma.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Oncology

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

Suchit Jhunjhunwala et al.

Summary: This review discusses the importance of antigen presentation in the success of immune checkpoint inhibition therapy and mechanisms by which tumors evade immune recognition. Tumors evade immune recognition by modulating antigen expression and altering antigen presentation.

NATURE REVIEWS CANCER (2021)

Add to Collection

Review Oncology

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Daniela Bruni et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Multidisciplinary Sciences

Neoantigen-directed immune escape in lung cancer evolution

Rachel Rosenthal et al.

NATURE (2019)

Add to Collection

Article Medicine, General & Internal

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah-Eddin Al-Batran et al.

LANCET (2019)

Add to Collection

Article Pathology

Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability

Meike Kohlruss et al.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)

Add to Collection

Review Oncology

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Jonathan J. Havel et al.

NATURE REVIEWS CANCER (2019)

Add to Collection

Article Oncology

Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinoma

Silvia Spoerl et al.

EUROPEAN JOURNAL OF CANCER (2018)

Add to Collection

Review Oncology

Determinants and clinical implications of chromosomal instability in cancer

Laurent Sansregret et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article Genetics & Heredity

HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

Maria A. Garrido et al.

IMMUNOGENETICS (2018)

Add to Collection

Article Multidisciplinary Sciences

A microsatellite based multiplex PCR method for the detection of chromosomal instability in gastric cancer

Meike Kohlruss et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Oncology

A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer

L. Bauer et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy

Teresa Davoli et al.

SCIENCE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan et al.

CELL (2017)

Add to Collection

Article Surgery

Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas A Summary of 480 Cases

Karen Becker et al.

ANNALS OF SURGERY (2011)

Add to Collection

Article Genetics & Heredity

Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

Isabel Maleno et al.

IMMUNOGENETICS (2011)

Add to Collection

Review Oncology

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible hard lesions

Federico Garrido et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)

Add to Collection

Article Biochemical Research Methods

Multiplex Manager 1.0: a cross-platform computer program that plans and optimizes multiplex PCR

Clare E. Holleley et al.

BIOTECHNIQUES (2009)

Add to Collection

Article Oncology

Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis

Simona Frigerio et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Add to Collection

Article Pathology

Loss of heterozygosity at 15q21.3 correlates with occurrence of metastases in head and neck cancer

Micaela Poetsch et al.

MODERN PATHOLOGY (2006)

Add to Collection

Article Medicine, General & Internal

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

David Cunningham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Add to Collection

Article Cell Biology

Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis

PA Gourraud et al.

TISSUE ANTIGENS (2004)

Add to Collection

Article Oncology

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

K Becker et al.

CANCER (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.